DividendInvestor.com
First In Dividend Data Worldwide®
DIVIDEND ANNOUNCEMENT: Gilead Sciences Inc (NASDAQ:GILD) on 02/04/2020 declared a dividend of $0.6800 per share
Gilead Sciences Inc (NASDAQ:GILD) on 02/04/2020 declared a dividend of $ 0.6800 per share payable on March 30, 2020 to shareholders of record as of March 13, 2020. Dividend amount recorded is an increase of $ 0.05 from last dividend Paid.
Gilead Sciences Inc (NASDAQ:GILD) has paid dividends since 2015, has a current dividend yield of 4.0988545418% and has increased its dividends for 4 successive years.
Gilead Sciences Inc's market cap is $ 83,955,088,560 and has a PE ratio of 31.45. The stock price closed yesterday at $ 66.36 and has a 52 week low/high of $ 60.89 and $ 70.26.
Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include HIV/AIDS, liver diseases, hematology/oncology and inflammation/respiratory diseases. Co.'s products include Biktarvy for the treatment of HIV-1 infection in certain patients, Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease, Yescarta (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, and Letairis® (ambrisentan) for the treatment of pulmonary arterial hypertension.
For more information on Gilead Sciences Inc click here.
Dividend Ex Date: March 12, 2020
Dividend Record Date: March 13, 2020
Dividend Payment Date: March 30, 2020
Dividend Amount: $ 0.6800
GILD LINKS
GILD Dividend History Detail
GILD Projected 10 Year Dividend Yield
GILD Dividend News
GILD Competitors News
DividendInvestor.com
DividendInvestor.com is a leading worldwide independent provider of dividend information and data for investment professionals. Our mission is to be the First In Dividend Data Worldwide® by designing and developing essential tools and systems for the investment community with the highest level of accuracy and integrity.
Contact:
info@DividendInvestor.com